Target Validation Information
Target ID T04507
Target Name Presynaptic density protein 95
Target Type
Clinical Trial
Drug Potency against Target N-Cyclohexylmethyl-ETAV Drug Info Ki = 1300 nM [529713]
N-(3,4-Dichlorophenyl)propyl-ETAV Drug Info Ki = 1100 nM [529713]
N-Phenylpropyl-ETAV Drug Info Ki = 3100 nM [529713]
N-Butyl-ETAV Drug Info Ki = 4000 nM [529713]
N-Cyclohexylethyl-ETAV Drug Info Ki = 450 nM [529713]
N-Benzyl-ETAV Drug Info Ki = 5200 nM [529713]
N-(Naphthalene-2-yl)ethyl-ETAV Drug Info Ki = 950 nM [529713]
N-(3,4-Difluorophenyl)propyl-ETAV Drug Info Ki = 1000 nM [529713]
KSG-YEKLSSIESDV Drug Info Ki = 7000 nM [529713]
N-Propyl-ETAV Drug Info Ki = 4200 nM [529713]
N-Phenylethyl-ETAV Drug Info Ki = 1600 nM [529713]
N-Methyl-ETAV Drug Info Ki = 8900 nM [529713]
KSG-LDTKNYKQTSV Drug Info Ki = 2100 nM [529713]
YGRKKRRQRRR-KLSSIESDV Drug Info Ki = 14000 nM [529713]
FETAV Drug Info Ki = 2300 nM [529713]
N-Ethyl-ETAV Drug Info Ki = 9600 nM [529713]
References
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.
Ref 529713J Med Chem. 2008 Oct 23;51(20):6450-9. Epub 2008 Sep 24.Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.